Transforming growth factor-beta-activated kinase 1-TAK1-binding protein 1 kinase complex (TAK1-TAB1)

The Transforming growth factor-beta-activated kinase 1-TAK1-binding protein 1 (TAK1-TAB1) kinase complex is a central signaling hub that integrates various stimuli, including proinflammatory cytokines (TNF-alpha, IL-1beta), Toll-like receptor (TLR) ligands, and TGF-beta (2.4.1, 3.1.1). It consists of the catalytic subunit TAK1 (also known as MAP3K7) and its essential regulatory subunit TAB1, which is required for the autophosphorylation and full activation of the kinase (2.2.2, 3.1.2). This complex plays a pivotal role in activating the NF-kappaB and mitogen-activated protein kinase (MAPK) pathways, which are critical for immune responses, cell survival, and inflammation (2.2.1, 2.4.5). Dysregulation of the TAK1-TAB1 complex is implicated in various diseases, including chronic inflammatory disorders like rheumatoid arthritis, and several types of cancer where it promotes tumor cell survival and chemoresistance (2.3.1, 3.4.3). Consequently, it has emerged as a promising therapeutic target, with several small-molecule inhibitors such as takinib and HS-276 under development to modulate its activity (3.1.1, 3.3.2). However, therapeutic advancement is challenged by the complex's essential role in normal development and the potential for systemic toxicity (2.4.1, 3.3.1).

Other names

MAP3K7-MAP3K7IP1 complexTGF-beta-activated kinase 1-binding protein 1 complexTAK1-TAB1 signalosomeMitogen-activated protein kinase kinase kinase 7-TAK1-binding protein 1 complex

Inhibition of TAK1 kinase activity, disruption of the TAK1-TAB1 protein-protein interaction, and sensitization of cells to TNF-alpha-induced apoptosis.